827
Participants
Start Date
June 11, 2018
Primary Completion Date
October 26, 2020
Study Completion Date
February 26, 2025
Pembrolizumab
200 mg administered by IV infusion on Day 1 of each 21-day cycle.
Lenvatinib
20 mg administered orally (PO) QD during each 21-day cycle.
Paclitaxel
80 mg/m\^2 administered by IV on a 28-day cycle: 3 weeks receiving paclitaxel once a week and 1 week not receiving paclitaxel.
Doxorubicin
60 mg/m\^2 administered by IV on Day 1 of each 21-day cycle.
Policlinico Universitario Agostino Gemelli, Roma
Kaohsiung Veterans General Hospital, Kaohsiung City
Kaohsiung Chang Gung Memorial Hospital of the C.G.M.F., Kaohsiung City
Auckland City Hospital, Auckland
Royal North Shore Hospital, Sydney
Peter MacCallum Cancer Centre, Melbourne
Seoul National University Hospital, Seoul
Grupo Medico Camino SC, Mexico City
Royal Brisbane and Women s Hospital, Herston
Asan Medical Center, Seoul
St John of God, Subiaco
Samsung Medical Center, Seoul
Hospital General Universitari Vall d Hebron, Barcelona
Instituto Catalan de Oncologia ICO - Hospital Duran i Reynals, L'Hospitalet de Llobregat
National Taiwan University Hospital, Taipei
Memorial Sloan Kettering Cancer Center, New York
National Cancer Center, Goyang-si
Taipei Veterans General Hospital, Taipei
Centre de Lutte Contre le Cancer Francois Baclesse, Caen
University of Rochester, Rochester
Acibadem Bursa Hastanesi, Bursa
Ospedale San Raffaele, Milan
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan
Istituto Europeo di Oncologia, Milan
Maryland Oncology Hematology, P.A., Wheaton
Greater Baltimore Medical Center, Baltimore
Centre Armoricain de Radiotherapie Imagerie medicale et Oncologie, Plérin
Investigacion Onco Farmaceutica S de RL de CV, La Paz
Duke University Medical Center, Durham
Hospital Universitario Gregorio Maranon, Madrid
Clinica Universitaria Navarra - Madrid, Madrid
Hospital Ramon y Cajal, Madrid
Hospital Clinico San Carlos, Madrid
Georgia Cancer Center at Augusta University, Augusta
Florida Hospital Cancer Institute, Orlando
Institut Bergonie, Bordeaux
University of Miami Health System, Miami
Chang Gung Medical Foundation. Linkou Branch, Taoyuan District
Institut Regional du Cancer de Montpellier - ICM, Montpellier
Acibadem Universitesi Atakent Hastanesi, Istanbul
Florence Nightingale Gayrettepe Hastanesi, Istanbul
Ege Universitesi Tip Fakultesi, Izmir
Centre Eugene Marquis, Rennes
UT West Cancer Center, Germantown
Taichung Veterans General Hospital, Taichung
Hopital prive du Confluent, Nantes
Hospital Universitario y Politecnico La Fe de Valencia, Valencia
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Meldola
Rodrigo Botero SAS, Medellín
Fundacion Colombiana de Cancerologia Clinica Vida, Medellín
Centro Hemato Oncologico Privado, Toluca
Sanford Gynecology Oncology, Sioux Falls
Centre Oscar Lambret, Lille
North Shore University Health System, Evanston
Alivia Clinica de Alta Especialidad S.A. de C.V., Monterrey
Centre Leon Berard, Lyon
Centre Hospitalier Lyon Sud, Pierre-Bénite
University Medical Center New Orleans, New Orleans
Stephenson Cancer Center, Oklahoma City
Groupe Hospitalier Broca Cochin Hotel Dieu, Paris
Hopital Diaconesses Croix Saint Simon, Paris
The University of Texas MD Anderson Cancer Center, Houston
Texas Oncology-San Antonio Medical Center, San Antonio
Texas Oncology-South Austin, Austin
Istituto Nazionale Tumori IRCCS Fondazione Pascale, Napoli
Soroka Medical Center, Beersheba
Utah Cancer Specialists, Salt Lake City
Arizona Oncology Associates, PC- HAL, Phoenix
University of California Los Angeles, Santa Monica
Faicic S de RL de CV, Veracruz
University of California San Francisco, San Francisco
Institut Gustave Roussy, Villejuif
Azienda Ospedaliera per l Emergenza Cannizzaro, Catania
Willamette Valley Cancer Institute and Research Center, Eugene
Clinica del Country, Bogota
Clinica Colsanitas S.A. - Sede Clinica Universitaria Colombia, Bogotá
FSBI National Medical Oncology Research Center n.a. N.N. Blokhina, Moscow
FSBI-FRCC of Special Types Med. Care & Technologies FMBA of Russia, Moscow
Leningrad Regional Oncology Center, Saint Petersburg
SPb SBHI City Clinical Oncological Dispensary, Saint Petersburg
Oncomedica S.A., Montería
Republican Clinical Oncology Dispensary of Tatarstan MoH, Kazan'
Mordovia Republican Oncological Dispensary, Saransk
Republican Clinical Oncology Dispensary of Republic of Bashkortostan, Ufa
Tomsk National Research Medical Center of Russian Academy of Sciences, Tomsk
Altay Regional Oncology Dispensary, Barnaul
Fundacion Valle del Lili, Santiago de Cali
Rambam Medical Center, Haifa
Rabin Medical Center, Petah Tikva
Chaim Sheba Medical Center, Ramat Gan
Edith Wolfson Medical Center, Holon
Hadassah Medical Center. Ein Kerem, Jerusalem
Smilow Cancer Hospital at Yale New Haven, New Haven
John Theurer Cancer Center at Hackensack University Med Ctr, Hackensack
Holy Name Medical Center, Teaneck
University of Texas Southwestern Medical Center at Dallas, Dallas
Centro de Oncologia e Investigacion Buenos Aires COIBA, Berazategui
Hospital Privado de la Comunidad, Mar del Plata
Instituto de Investigaciones Metabolicas, Buenos Aires
Hospital Aleman, Buenos Aires
Instituto de Oncologia Angel H. Roffo, Buenos Aires
Instituto Medico Especializado Alexander Fleming, Buenos Aires
Centro Oncologico Riojano Integral, La Rioja
Hospital Araujo Jorge, Goiânia
Instituto Nacional do Cancer II, Rio de Janeiro
Hospital de Clinicas de Porto Alegre, Porto Alegre
Uniao Brasileira de Educacao e Assistencia Hospital Sao Lucas da Pucrs, Porto Alegre
Fundacao Dr Amaral Carvalho, Jaú
Instituto do Cancer de Sao Paulo - ICESP, São Paulo
Clinica de Pesquisas e Ctro de Estudos Onc. Ginecol. e Mamaria Ltda, São Paulo
Faculdade de Medicina da Universidade Federal de Minas Gerais, Belo Horizonte
Tom Baker Cancer Centre, Calgary
Cancer Care Manitoba, Winnipeg
London Health Sciences Centre, London
Ottawa General Hospital, Ottawa
Sunnybrook Health Science Centre, Toronto
Princess Margaret Cancer Centre, Toronto
CIUSSS de l Est de L Ile de Montreal - Hopital Maisonneuve-Rosemont, Montreal
Centre Hospitalier de l Universite de Montreal - CHUM, Montreal
Jewish General Hospital, Montreal
CIUSSS de l'Estrie-CHUS, Sherbrooke
CHU de Quebec-Universite Laval-Hotel Dieu de Quebec, Québec
Biomelab S A S, Barranquilla
EISAI Trial Site 4, Berlin
EISAI Trial Site 2, Dresden
EISAI Trial Site 1, Erlangen
EISAI Trial Site 6, Hamburg
EISAI Trial Site 3, Rostock
EISAI Trial Site 5, Tübingen
EISAI Trial Site 9, Nagoya
EISAI Trial Site 18, Kashiwa
EISAI Trial Site 7, Matsuyama
EISAI Trial Site 15, Tōon
EISAI Trial Site 5, Kurume
EISAI Trial Site 11, Sapporo
EISAI Trial Site 8, Akashi
EISAI Trial Site 17, Tsukuba
EISAI Trial Site 4, Morioka
EISAI Trial Site 19, Isehara
EISAI Trial Site 14, Sendai
EISAI Trial Site 1, Hidaka
EISAI Trial Site 2, Sunto-gun
EISAI Trial Site 16, Kagoshima
EISAI Trial Site 3, Niigata
EISAI Trial Site 10, Tokyo
EISAI Trial Site 12, Tokyo
EISAI Trial Site 13, Tokyo
EISAI Trial Site 6, Tokyo
Mater Misericordiae University Hospital, Dublin
Centrum Onkologii Instytut im. Marii Sklodowskiej Curie, Krakow
Centrum Onkologii. Instytut im. Marii Sklodowskiej-Curie, Warsaw
Beskidzkie Centrum Onkologii im. Jana Pawla II, Bielsko-Biala
Szpital Morski im. PCK Szpitale Wojewodzkie w Gdyni Sp. z o.o., Gdynia
Centrum Onkologii Instytut im. Marii Sklodowskiej Curie, Gliwice
Instytut Centrum Zdrowia Matki Polki, Lodz
Pomorski Uniwersytet Medyczny w Szczecinie, Szczecin
Szpital Kliniczny im Ks Anny Mazowieckiej, Warsaw
Basken Adana Dr.Turgut Noyan Uygulama ve Arastirma Merkezi, Adana
Hacettepe University Medical Faculty, Ankara
Baskent Universitesi Ankara Hastanesi, Ankara
Royal Sussex County Hospital, Brighton
Addenbrookes Hospital, Cambridge
Barts Health NHS Trust - St Bartholomew s Hospital, London
Guy s & St Thomas NHS Foundation Trust, London
The Royal Marsden Foundation Trust, London
The Royal Marsden NHS Foundation Trust, London
Imperial College Healthcare NHS Trust, London
University College Hospital, London
University Hospital Southampton NHS Foundation Trust, Southampton
Merck Sharp & Dohme LLC
INDUSTRY
Eisai Inc.
INDUSTRY